TerminatedPhase 2NCT04402073
Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Peter HauEORTC study coordinator
- Intervention
- Sonidegib(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2022 – 2025
Study locations (30)
- Royal Adelaide Hospital, Adelaide, Australia
- Princess Alexandra Hospital - University Of Queensland, Brisbane, Australia
- Austin Health - Austin hospital, Melbourne, Australia
- Peter Maccallum Cancer Institute, Melbourne, Australia
- Sir Charles Gairdner Hospital, Nedlands, Australia
- John Hunter Children's Hospital, New Lambton Heights, Australia
- Prince Of Wales Hospital, Sydney, Australia
- Royal North Shore Hospital, Sydney, Australia
- Sydney Children's Hospital, Sydney, Australia
- Westmead Hospital - Crown Princess Mary Cancer Center, Westmead, Australia
- A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck, Austria
- AKH unikliniken, Vienna, Austria
- CHRU de Lille, Lille, France
- Centre Leon Berard, Lyon, France
- Hopital de La Timone (APHM), Marseille, France
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04402073 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS